Literature DB >> 21962190

Unusual case of proximal calciphylaxis without renal failure.

Monica Stanciu1, Angélique Gagné-Henley, Geneviève Thérien.   

Abstract

BACKGROUND: Calciphylaxis is a rare syndrome of vascular calcification with subsequent cutaneous and tissue necrosis. It usually manifests as a complication of end-stage renal failure, affecting 1 to 4% of long-term dialysis patients. Very exceptionally, it can occur without chronic renal failure.
OBJECTIVE: The goal of this study was to discuss an exceptional case of extensive calciphylaxis in the absence of chronic renal failure and its successful management.
METHODS: We present a case of a 31-year-old woman with extensive proximal, ulcerated calciphylaxis without associated chronic renal failure. Our patient had quite a few risk factors associated with the pathogenesis of calciphylaxis, such as obesity, malnutrition, and a transient episode of acute renal failure.
RESULTS: She was successfully treated with sodium thiosulfate, extensive wound débridement (more than 30% total body surface), and subsequent skin grafts. The patient has miraculously survived this often fatal condition.
CONCLUSION: Calciphylaxis can occur even in the absence of chronic renal failure. This often fatal condition can be managed successfully with a combination of aggressive wound control and the fairly newly described sodium thiosulfate therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21962190     DOI: 10.2310/7750.2011.10046

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  2 in total

1.  Sodium thiosulfate in the treatment of calciphylaxis.

Authors:  George F Cohen; Nikki S Vyas
Journal:  J Clin Aesthet Dermatol       Date:  2013-05

2.  Topical cannabis-based medicines - A novel paradigm and treatment for non-uremic calciphylaxis leg ulcers: An open label trial.

Authors:  Vincent Maida; Runjie B Shi; Francesco G T Fazzari; Lydia Zomparelli
Journal:  Int Wound J       Date:  2020-09-02       Impact factor: 3.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.